mebendazole has been researched along with Breast Neoplasms in 6 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here we applied Silicon Nanowire (SiNW) array electrodes (in an integrated architecture of working, counter and reference electrodes) grown by low pressure chemical vapor deposition (LPCVD) system with VLS procedure to electrochemically diagnose the presence of breast cancer cells as well as their response to anticancer drugs." | 7.83 | Silicon nanowire based biosensing platform for electrochemical sensing of Mebendazole drug activity on breast cancer cells. ( Abdolahad, M; Alikhani, A; Faramarzpour, M; Hassanpour, M; Namdar, N; Shashaani, H, 2016) |
| "Flubendazole inhibited breast cancer cells proliferation in dose- and time-dependent manner and delayed tumor growth in xenograft models by intraperitoneal injection." | 5.42 | Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells. ( Cui, B; Hou, ZJ; Li, GH; Liu, Q; Long, ZJ; Luo, X; Peng, F; Wan, XY; Wang, XT; Wu, SJ; Xu, J; Xu, LZ; Yang, YL; Zhang, W; Zheng, FM, 2015) |
| "Flubendazole was validated for its anti-proliferative efficacy in MDA-MB-231 cells." | 5.42 | Systems biology-based discovery of a potential Atg4B agonist (Flubendazole) that induces autophagy in breast cancer. ( Guo, M; Li, J; Liu, B; Xie, T; Zhang, L; Zhang, S; Zheng, Y, 2015) |
| " Here we applied Silicon Nanowire (SiNW) array electrodes (in an integrated architecture of working, counter and reference electrodes) grown by low pressure chemical vapor deposition (LPCVD) system with VLS procedure to electrochemically diagnose the presence of breast cancer cells as well as their response to anticancer drugs." | 3.83 | Silicon nanowire based biosensing platform for electrochemical sensing of Mebendazole drug activity on breast cancer cells. ( Abdolahad, M; Alikhani, A; Faramarzpour, M; Hassanpour, M; Namdar, N; Shashaani, H, 2016) |
| "We compare their efficacy in breast and colon cancer cell lines as well as in non-cancerous cells and elucidate their mechanism of action." | 1.62 | Treatment of breast and colon cancer cell lines with anti-helmintic benzimidazoles mebendazole or albendazole results in selective apoptotic cell death. ( Baird, SK; Petersen, JSSM, 2021) |
| "Flubendazole inhibited breast cancer cells proliferation in dose- and time-dependent manner and delayed tumor growth in xenograft models by intraperitoneal injection." | 1.42 | Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells. ( Cui, B; Hou, ZJ; Li, GH; Liu, Q; Long, ZJ; Luo, X; Peng, F; Wan, XY; Wang, XT; Wu, SJ; Xu, J; Xu, LZ; Yang, YL; Zhang, W; Zheng, FM, 2015) |
| "Flubendazole was validated for its anti-proliferative efficacy in MDA-MB-231 cells." | 1.42 | Systems biology-based discovery of a potential Atg4B agonist (Flubendazole) that induces autophagy in breast cancer. ( Guo, M; Li, J; Liu, B; Xie, T; Zhang, L; Zhang, S; Zheng, Y, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gales, L | 1 |
| Forsea, L | 1 |
| Mitrea, D | 1 |
| Stefanica, I | 1 |
| Stanculescu, I | 1 |
| Mitrica, R | 1 |
| Georgescu, M | 1 |
| Trifanescu, O | 1 |
| Anghel, R | 1 |
| Serbanescu, L | 1 |
| Petersen, JSSM | 1 |
| Baird, SK | 1 |
| Hou, ZJ | 1 |
| Luo, X | 1 |
| Zhang, W | 1 |
| Peng, F | 1 |
| Cui, B | 1 |
| Wu, SJ | 1 |
| Zheng, FM | 1 |
| Xu, J | 1 |
| Xu, LZ | 1 |
| Long, ZJ | 1 |
| Wang, XT | 1 |
| Li, GH | 1 |
| Wan, XY | 1 |
| Yang, YL | 1 |
| Liu, Q | 1 |
| Zhang, L | 1 |
| Guo, M | 1 |
| Li, J | 1 |
| Zheng, Y | 1 |
| Zhang, S | 1 |
| Xie, T | 1 |
| Liu, B | 1 |
| Shashaani, H | 1 |
| Faramarzpour, M | 1 |
| Hassanpour, M | 1 |
| Namdar, N | 2 |
| Alikhani, A | 1 |
| Abdolahad, M | 2 |
| Zanganeh, S | 1 |
| Khosravi, S | 1 |
| Amiri, MH | 1 |
| Gharooni, M | 1 |
1 review available for mebendazole and Breast Neoplasms
| Article | Year |
|---|---|
Antidiabetics, Anthelmintics, Statins, and Beta-Blockers as Co-Adjuvant Drugs in Cancer Therapy.
Topics: Adenosine Monophosphate; Adrenergic beta-Antagonists; Anthelmintics; Anti-Bacterial Agents; Antihype | 2022 |
5 other studies available for mebendazole and Breast Neoplasms
| Article | Year |
|---|---|
Treatment of breast and colon cancer cell lines with anti-helmintic benzimidazoles mebendazole or albendazole results in selective apoptotic cell death.
Topics: Albendazole; Anthelmintics; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Proliferation; Colonic Neo | 2021 |
Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.
Topics: Animals; Antinematodal Agents; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proli | 2015 |
Systems biology-based discovery of a potential Atg4B agonist (Flubendazole) that induces autophagy in breast cancer.
Topics: Antineoplastic Agents; Autophagy; Autophagy-Related Proteins; Breast Neoplasms; Cell Line, Tumor; Cy | 2015 |
Silicon nanowire based biosensing platform for electrochemical sensing of Mebendazole drug activity on breast cancer cells.
Topics: Biosensing Techniques; Breast; Breast Neoplasms; Cytochromes c; Drug Screening Assays, Antitumor; El | 2016 |
Electrochemical approach for monitoring the effect of anti tubulin drugs on breast cancer cells based on silicon nanograss electrodes.
Topics: Breast Neoplasms; Electrodes; Female; Humans; MCF-7 Cells; Mebendazole; Nanotechnology; Paclitaxel; | 2016 |